Avadel Pharmaceuticals Plc (AVDL)
21.31
-0.01
(-0.05%)
USD |
NASDAQ |
Dec 09, 16:00
21.30
-0.02
(-0.07%)
After-Hours: 20:00
Avadel Pharmaceuticals Shareholders Equity (Quarterly): 98.22M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Alkermes Plc | 1.733B |
| Jazz Pharmaceuticals Plc | 3.959B |
| Medtronic Plc | 48.65B |
| STERIS Plc (Ireland) | 7.009B |
| Amarin Corp. Plc | 458.89M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 199.45M |
| Total Liabilities (Quarterly) | 101.22M |
| Debt to Equity Ratio | 0.3805 |
| Current Ratio | 2.756 |
| Net Debt Paydown Yield | 0.00% |